1. Autophagy. 2016 Nov;12(11):2254-2255. doi: 10.1080/15548627.2016.1216303. Epub
 2016 Aug 19.

Unconventional autophagy mediated by the WD40 domain of ATG16L1 is derailed by 
the T300A Crohn disease risk polymorphism.

Serramito-Gómez I(1), Boada-Romero E(1), Pimentel-Muiños FX(1).

Author information:
(1)a Instituto de Biología Molecular y Celular del Cáncer, (CSIC-Universidad de 
Salamanca), Centro de Investigación del Cáncer , Campus Miguel de Unamuno, 
Universidad de Salamanca , Salamanca , Spain.

Comment on
    Punctum to: Boada-Romero E, Serramito-Gómez I, Sacristán MP, Boone DL, 
Xavier RJ, Pimentel-Muiños FX. The T300A Crohn's disease risk polymorphism 
impairs function of the WD40 domain of ATG16L1. Nat Commun 2016; 7:11821; 
http://dx.doi.org/10.1038/ncomms11821.

A coding polymorphism of the critical autophagic effector ATG16L1 (T300A) 
increases the risk of Crohn disease, but how this mutation influences the 
function of ATG16L1 has remained unclear. In a recent report, we showed that the 
A300 allele alters the ability of the C-terminal WD40 domain of ATG16L1 to 
interact with proteins containing a specific amino acid motif able to recognize 
this region. This defect impairs the capacity of the motif-containing 
transmembrane molecule TMEM59 to induce the unconventional autophagic labeling 
of the same single-membrane vesicles where this protein is located. Such 
alteration derails the intracellular trafficking of TMEM59 and the xenophagic 
response against bacterial infection. In contrast, canonical autophagy remains 
unaffected in the presence of ATG16L1T300A. These data argue that the T300A 
polymorphism impairs the unconventional autophagic activities carried out by the 
WD40 domain, a region of ATG16L1 whose function has remained poorly understood.

DOI: 10.1080/15548627.2016.1216303
PMCID: PMC5103359
PMID: 27541200 [Indexed for MEDLINE]